Alkaline Glyburide Formulation for Low-Sorption Infusion Dosing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Glyburide formulations suffer from reduced concentration due to sorption to delivery tubing and containers, instability, and low solubility in typical pH ranges, leading to unstable and imprecise dosing, which is critical in emergency medical settings.
Innovation Solution
Formulations comprising glyburide, a buffering agent, and a sugar alcohol with a pH outside the buffering agent's capacity, stabilizing the solution and minimizing sorption, ensuring a predictable and accurate dose.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If glyburide is formulated in buffered aqueous solutions at typical pH ranges (pH 5-9), then the solution is pharmaceutically acceptable for infusion, but the solubility of glyburide is extremely low and concentration is reduced due to sorption
Solution Approach 1:
The patent changes the pH parameter from the typical infusion range (pH 5-9) to an alkaline range (pH 10-12), which dramatically increases glyburide solubility from extremely low levels to concentrations sufficient for therapeutic dosing. This parameter change resolves the contradiction by maintaining pharmaceutical acceptability while achieving the required drug concentration.
Solution Approach 2:
The patent introduces sodium hydroxide as an intermediary substance to adjust and maintain the alkaline pH environment. This mediator enables the formulation to achieve both high glyburide solubility and stability in the alkaline range, resolving the contradiction between solubility and pharmaceutical acceptability.
2Ease of operation
If glyburide formulations are stored and delivered using conventional polymeric containers and delivery tubing, then the equipment is readily available and easy to use, but significant amounts of glyburide (40-50%) are lost due to sorption
Solution Approach 1:
The patent changes the pH parameter to alkaline conditions (pH 10-12), which fundamentally alters the interaction between glyburide and polymeric surfaces. This parameter change eliminates the sorption mechanism that causes 40-50% drug loss, allowing the use of conventional polymeric delivery equipment without significant drug loss.
Solution Approach 2:
The patent converts the harmful sorption interaction into a beneficial non-sorbing interaction by changing the pH environment. The alkaline conditions transform the chemical properties of both glyburide and the polymeric surfaces, turning the previously harmful adsorption mechanism into a neutral or beneficial non-interaction state.
3Manufacturing precision
If glyburide formulations are prepared to achieve therapeutic concentrations, then adequate dosing is possible, but the formulations become unstable and imprecise due to sorption and degradation
Solution Approach 1:
The patent changes the pH parameter to an alkaline range (pH 10-12) where glyburide exhibits both high solubility and enhanced stability. This parameter change simultaneously achieves precise dosing concentrations and formulation stability, resolving the contradiction between dosing accuracy and formulation stability.
Solution Approach 2:
The patent inverts the conventional approach by not trying to stabilize glyburide at acidic or neutral pH, but rather by stabilizing it at alkaline pH. This inversion of the pH approach fundamentally changes the chemical environment to prevent degradation and sorption, achieving both stability and dosing precision.
4Loss of substance
If specialized low-sorbing infusion sets are used to reduce glyburide loss, then drug loss is minimized, but the complexity of the system increases and sourcing becomes difficult
Solution Approach 1:
The patent creates a chemical environment (alkaline pH) that replicates the effect of specialized low-sorbing infusion sets, but using conventional equipment. By changing the pH parameter, the formulation itself becomes resistant to sorption, eliminating the need for specialized devices while achieving the same drug loss prevention.
Solution Approach 2:
The patent makes the glyburide formulation itself resistant to sorption through alkaline pH conditions, allowing it to work effectively with conventional equipment without requiring specialized infusion sets. The formulation self-protects against drug loss, eliminating the need for complex specialized devices.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulations maintain glyburide stability and solubility, reducing waste and cost by minimizing sorption to delivery materials, allowing precise dosing without specialized equipment, and maintaining pH stability during infusion.
Implementation Method 1
a buffering agent, wherein the formulation has a pH outside of the buffering capacity of the buffering agent
Implementation Method 2
Glyburide formulations suffer from reduced concentration due to sorption to delivery tubing and containers
Data Source
AI summary
Methods and formulations for minimizing or avoiding the sorption of glyburide to surfaces of delivery tubing, filters, bags, and other containers and materials, thereby storing and delivering a more stable product, delivering a predictable and accurate dose of glyburide, while minimizing impurities, avoiding drug waste, reducing cost, and significantly reducing the amount of dosing solution that must be infused into the patient.